introduct
studi
compar
detect
common
respiratori
virus
two
differ
realtim
revers
transcript
polymeras
chain
reaction
rrtpcr
method
hous
singleplex
test
develop
center
diseas
control
prevent
commerci
avail
fast
track
diagnost
respiratori
pathogen
multiplex
test
method
total
nasopharyng
swab
analyz
use
cdc
singleplex
rrtpcr
respiratori
pathogen
multiplex
assay
detect
respiratori
virus
result
result
show
sampl
posit
singleplex
method
respiratori
pathogen
multiplex
test
excel
satisfactori
agreement
obtain
virus
k
n
except
parainfluenzaviru
k
influenza
b
k
conclus
although
multiplex
ftd
kit
expens
singleplex
assay
ftd
kit
yield
rapid
result
shorter
timefram
increas
effici
diagnosi
acut
respiratori
infect
ari
one
lead
caus
hospit
morbid
mortal
worldwid
data
metaanalysi
studi
show
approxim
million
children
year
worldwid
die
due
infect
liu
et
al
burden
ari
particularli
high
subsaharan
africa
record
nearli
half
death
million
liu
et
al
avail
data
indic
viral
agent
play
import
role
global
caus
ari
cilla
et
al
antigen
detect
immunofluoresc
enzymelink
immunosorb
assay
elisa
cultur
still
occasion
use
confirm
infect
respiratori
virus
ginocchio
tradit
method
sever
limit
viral
cultur
exampl
time
consum
labor
intens
requir
substanti
technic
expertis
maintain
evalu
cell
cultur
monolay
leland
ginocchio
current
nucleic
acid
amplif
method
choic
diagnosi
respiratori
infect
bierbaum
et
al
driscol
et
al
kenmo
et
al
lagar
et
al
malhotra
et
al
molecular
test
wide
recogn
contribut
better
effici
sensit
speed
compar
tradit
method
diagnosi
respiratori
infect
sever
hous
method
describ
includ
panel
singleplex
assay
detect
respiratori
virus
center
diseas
control
prevent
cdc
njouom
et
al
sakthivel
et
al
analys
respiratori
pathogen
use
individu
realtim
revers
transcript
polymeras
chain
reaction
rrtpcr
howev
labori
time
consum
recent
sever
multiplex
rrtpcr
commerci
method
becom
avail
detect
respiratori
pathogen
anderson
et
al
barratt
et
al
driscol
et
al
malhotra
et
al
time
multiplex
panel
capabl
simultan
detect
three
respiratori
pathogen
wide
avail
introduct
new
multiplex
method
allow
analysi
wider
rang
respiratori
pathogen
coupl
simplif
procedur
reduc
time
detect
sampl
volum
requir
risk
contamin
number
studi
compar
perform
respiratori
pathogen
kit
hous
respiratori
panel
commerci
panel
luminex
respiratori
pathogen
panel
luminex
molecular
diagnost
austin
tx
taqman
array
thermo
fischer
scientif
respiratori
viru
panel
assay
seegen
anderson
et
al
barratt
et
al
bierbaum
et
al
driscol
et
al
malhotra
et
al
sakthivel
et
al
overal
report
show
respiratori
pathogen
kit
yield
similar
result
multiplex
pathogen
detect
kit
date
avail
data
perform
new
multiplex
test
use
africa
africa
contin
divers
socioeconom
cultur
context
yet
bear
greatest
burden
ari
term
morbid
mortal
liu
et
al
evalu
molecular
assay
context
cameroon
help
guid
prioriti
assay
select
routin
detect
respiratori
virus
multiplex
tool
enabl
detect
multipl
virus
within
singl
specimen
codetect
data
offer
insight
virus
present
sampl
less
clear
pattern
viru
combin
correl
clinic
manifest
us
food
drug
administr
ortiz
et
al
codetect
repres
multipl
organ
present
sampl
wherea
coinfect
suggest
organ
contribut
part
pathogen
koon
et
al
compar
multiplex
data
patient
vari
clinic
sever
offer
opportun
examin
potenti
differ
codetect
pattern
studi
compar
perform
respiratori
pathogen
singleplex
cdc
assay
detect
respiratori
virus
use
respiratori
sampl
collect
part
sentinel
surveil
influenza
viru
cameroon
compar
time
cost
necessari
run
respiratori
pathogen
singleplex
cdc
assay
cameroon
examin
codetect
pattern
associ
among
hospit
nonhospit
patient
test
studi
perform
cameroon
nation
influenza
center
centr
pasteur
cameroon
cpc
retroprospect
crosssect
studi
conduct
bank
nasopharyng
swab
collect
sentinel
site
conduct
influenza
surveil
cameroon
repres
region
south
cameroon
fig
patient
recruit
octob
august
sampl
select
studi
origin
ambulatori
hospit
patient
acut
respiratori
infect
age
influenza
like
ill
ili
defin
ambulatori
patient
fever
cough
andor
sore
throat
onset
symptom
previou
day
ortiz
et
al
sever
acut
respiratori
infect
sari
addit
ili
clinic
present
requir
hospit
consent
particip
studi
obtain
part
routin
influenza
viru
surveil
studi
dispens
institut
ethic
clearanc
part
public
health
surveil
activ
archiv
nasopharyng
swab
process
previous
describ
sakthivel
et
al
includ
studi
nucleic
acid
extract
sampl
prospect
prescreen
influenza
influenza
b
rnase
p
intern
control
use
singleplex
cdc
method
kenmo
et
al
sampl
subsequ
store
second
analysi
respiratori
pathogen
singleplex
cdc
assay
two
new
extract
total
nucleic
acid
perform
sampl
intern
control
present
respiratori
pathogen
kit
extract
store
refriger
manipul
complet
day
avoid
degrad
nucleic
acid
freezingthaw
extract
conduct
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
accord
manufactur
recommend
sampl
test
singleplex
cdc
techniqu
accord
previous
describ
protocol
sakthivel
et
al
briefli
sampl
test
follow
addit
respiratori
viral
target
rhinoviru
extract
also
test
respiratori
pathogen
method
use
extract
sampl
per
pcr
plate
accord
manufactur
instruct
respiratori
pathogen
method
perform
tube
cover
virus
includ
influenza
influenza
b
influenza
rv
hpiv
hmpvab
hbov
hrsvab
hpev
ev
hadv
one
bacteria
mpneu
remain
assay
pool
ftd
kit
focu
bacteri
detect
data
assay
pool
test
studi
result
method
consid
posit
sigmoid
curv
cycl
threshold
ct
curv
per
specimen
cost
us
dollar
singleplex
cdc
method
respiratori
pathogen
kit
calcul
base
commerci
avail
price
primer
enzym
well
ftd
kit
respect
cost
plastic
consum
includ
calcul
labor
valid
cost
estim
per
hour
time
need
prepar
analyz
specimen
use
method
determin
accord
experi
cpc
target
includ
respiratori
pathogen
kit
influenza
hbov
ev
hpev
mpneu
compar
perform
evalu
posit
neg
percentag
agreement
ppa
npa
respect
obtain
follow
two
formula
us
repres
high
disagr
weak
agreement
weak
agreement
medium
agreement
satisfactori
agreement
excel
agreement
respect
statist
differ
two
compar
method
estim
use
mcnemar
test
first
data
respiratori
pathogen
method
alon
util
compar
codetect
sari
versu
ili
patient
method
test
respiratori
pathogen
separ
data
cdc
singleplex
method
util
compar
codetect
test
use
estim
statist
differ
proport
codetect
sari
versu
ili
patient
use
independ
ttest
mean
number
virus
compar
sari
specimen
equal
number
randomli
sampl
ili
specimen
analys
pvalu
consid
statist
signific
statist
analyz
conduct
use
r
version
r
core
team
patient
recruit
influenza
surveil
sentinel
site
octob
august
total
nasopharyng
specimen
per
month
randomli
select
studi
accord
age
locat
sex
major
sampl
origin
follow
bandjoun
douala
buea
foumban
bamenda
ebolowa
mean
age
studi
particip
year
rang
year
studi
includ
femal
male
patient
studi
popul
consist
ili
ambulatori
patient
sari
hospit
patient
includ
respiratori
viru
target
test
common
respiratori
pathogen
singleplex
cdc
assay
compar
analysi
tabl
target
influenza
show
agreement
respiratori
pathogen
singleplex
cdc
result
remain
pathogen
posit
percent
agreement
rang
hrsv
neg
percent
agreement
rang
hadv
excel
agreement
k
n
obtain
hrsv
hmpv
hadv
rv
influenza
target
agreement
respiratori
pathogen
singleplex
cdc
satisfactori
k
n
target
k
k
k
agreement
detect
influenza
b
averag
k
n
low
k
n
k
k
respect
accord
mcnemar
test
respiratori
pathogen
singleplex
cdc
test
show
signific
differ
detect
influenza
b
target
total
test
sampl
show
discrep
result
respiratori
pathogen
singleplex
cdc
techniqu
major
discrep
p
b
record
sampl
multipl
pathogen
detect
discrep
predomin
detect
hadv
follow
rv
influenza
b
ct
respiratori
pathogen
singleplex
cdc
discord
test
report
fig
b
discord
result
observ
sampl
low
viral
load
median
ct
n
except
rv
influenza
b
target
cost
calcul
estim
respiratori
pathogen
time
expens
test
pathogen
use
singleplex
cdc
assay
yet
time
fast
studi
singleplex
cdc
test
requir
approxim
hour
extract
amplif
sampl
includ
control
viral
target
two
manipul
respiratori
pathogen
techniqu
hand
requir
hour
extract
amplif
sampl
includ
control
target
singl
manipul
tabl
describ
theoret
reagent
labor
cost
associ
conduct
two
describ
method
sampl
cpc
total
cost
per
specimen
respiratori
pathogen
techniqu
singleplex
cdc
method
respect
cost
singleplex
cdc
assay
even
lower
test
fewer
virus
techniqu
similar
durat
analysi
amplif
result
overal
one
respiratori
virus
found
sampl
singleplex
cdc
respiratori
pathogen
assay
respect
singl
viru
detect
sampl
singleplex
cdc
respiratori
pathogen
assay
respect
multipl
detect
present
sampl
singleplex
cdc
assay
doubl
detect
tripl
detect
quadrupl
detect
sampl
respiratori
pathogen
assay
doubl
detect
tripl
detect
quadrupl
detect
quintupl
detect
except
inf
mpneu
respiratori
pathogen
test
detect
respiratori
viru
commonli
detect
singleplex
cdc
assay
respiratori
pathogen
hadv
follow
hrsv
rv
tabl
present
detect
frequenc
respiratori
pathogen
found
singleplex
cdc
respiratori
pathogen
assay
studi
use
ftd
multiplex
codetect
commonli
observ
ambulatori
outpati
compar
hospit
patient
p
sari
specimen
ili
specimen
multipl
virus
detect
sampl
compar
codetect
pattern
sari
specimen
random
sampl
ili
specimen
detect
hospit
patient
differ
viral
combin
combin
virus
combin
virus
compar
outpati
specimen
differ
viral
combin
combin
combin
combin
test
fewer
organ
use
cdc
singleplex
assay
strong
codetect
pattern
observ
sari
ili
specimen
multipl
virus
p
random
sampl
sari
specimen
viral
combin
ili
specimen
viral
combin
studi
singleplex
cdc
assay
compar
commerci
respiratori
pathogen
multiplex
test
detect
respiratori
virus
collect
sari
ili
case
six
region
cameroon
result
studi
show
two
method
excel
satisfactori
correl
detect
mani
viral
pathogen
test
except
two
virus
k
influenza
b
k
singleplex
assay
took
twice
long
multiplex
approxim
half
cost
sampl
test
techniqu
show
presenc
least
one
respiratori
viru
detect
rate
rel
higher
rate
obtain
previou
studi
cameroon
central
african
countri
could
explain
higher
number
respiratori
virus
test
studi
compar
et
al
studi
report
preval
ambulatori
hospit
children
recruit
central
african
republ
et
al
still
studi
detect
respiratori
virus
may
miss
detect
pathogen
lower
respiratori
tract
possibl
sinc
nasopharyng
specimen
analyz
depend
sampl
conduct
month
certain
pathogen
may
repres
overal
howev
viral
target
show
compar
detect
rate
techniqu
except
influenza
b
significantli
differ
even
though
kappa
valu
low
k
low
preval
may
limit
abil
detect
signific
differ
two
diagnost
test
detect
frequenc
rang
hadv
speci
detect
rate
differ
viral
target
consist
previou
studi
cameroon
african
countri
hoffmann
et
al
kenmo
et
al
lagar
et
al
lekanadouki
et
al
et
al
njouom
et
al
howev
noteworthi
accord
previou
studi
africa
dia
et
al
kenmo
et
al
mention
studi
confirm
predomin
frequenc
hadv
acut
respiratori
infect
region
twelv
influenza
hrsv
rv
hmpv
hadv
viral
target
test
reveal
excel
satisfactori
agreement
kappa
valu
respiratori
pathogen
singleplex
cdc
assay
similarli
previou
studi
compar
ftd
kit
commerci
person
test
singleplex
multiplex
shown
similar
result
anderson
et
al
barratt
et
al
bierbaum
et
al
driscol
et
al
malhotra
et
al
sakthivel
et
al
comparison
sensit
cdc
singleplex
assay
ftd
assay
respiratori
virus
test
prospect
specimen
previous
conduct
show
similar
sensit
assay
except
ftd
assay
hadv
rsv
rv
lower
sensit
ortiz
et
al
must
note
studi
conduct
sakthivel
et
al
differ
ftd
assay
kit
use
howev
kit
referenc
overlap
assay
kit
discuss
studi
good
concord
observ
hadv
evhpev
current
studi
differ
found
sakthivel
et
al
bierbaum
et
al
studi
compar
techniqu
bierbaum
et
al
sakthivel
et
al
result
could
explain
updat
primer
probe
sequenc
version
respiratori
pathogen
differ
version
respiratori
pathogen
use
prior
studi
import
featur
molecular
detect
assay
modif
primer
probe
sequenc
follow
mutat
viral
genom
sequenc
region
primer
probe
bind
unlik
current
studi
hadv
hbov
reveal
weak
agreement
compar
respiratori
pathogen
ep
respiratori
pathogen
studi
anderson
et
al
new
zealand
anderson
et
al
contrast
studi
k
influenza
b
k
target
low
agreement
previou
studi
show
good
agreement
barratt
et
al
malhotra
et
al
sakthivel
et
al
similar
previou
studi
major
discrep
observ
sampl
high
ct
valu
bierbaum
et
al
sakthivel
et
al
hypothes
higher
sampl
input
volum
use
respiratori
pathogen
versu
singleplex
cdc
assay
could
better
explain
observ
discrep
sampl
high
ct
valu
rather
differ
sensit
two
assay
although
volum
differ
minim
specimen
titer
near
limit
detect
pcr
even
small
differ
could
affect
detect
contrast
rv
influenza
b
target
show
discord
sampl
low
ct
rhinoviru
strain
known
exhibit
primer
specif
problem
difficult
design
singl
pair
primer
detect
rv
type
exclud
ev
type
faux
et
al
sakthivel
et
al
although
import
resolv
discrep
sensit
specif
molecular
techniqu
unfortun
unabl
address
studi
due
insuffici
sampl
volum
hand
studi
low
number
posit
obtain
influenza
target
could
reduc
accuraci
analysi
perform
target
therefor
addit
studi
base
larger
number
sampl
import
support
result
obtain
studi
target
cost
analys
compar
two
method
consist
literatur
show
person
singleplex
assay
less
expens
commerci
multiplex
kit
bierbaum
et
al
malhotra
et
al
find
howev
must
consid
context
intend
use
reagent
routin
surveil
benefit
gain
multiplex
kit
ie
multipl
pathogen
detect
rapid
result
may
worth
addit
financi
cost
contrast
emerg
outbreak
situat
benefit
multiplex
commerci
kit
may
well
worth
addit
price
futur
studi
consid
examin
laboratori
test
algorithm
use
differ
outbreak
routin
surveil
scenario
better
understand
costbenefit
tradeoff
addit
compar
perform
cost
two
diagnost
platform
abl
compar
viral
codetect
pattern
use
multiplex
singleplex
data
specimen
hospit
outpati
individu
use
multiplex
platform
test
pathogen
viral
codetect
pattern
nonhospit
ili
patient
heterogen
hospit
patient
often
singl
virus
fewer
viral
combin
codetect
observ
find
contrast
exist
literatur
metaanalysi
asner
et
al
find
differ
clinic
sever
singl
codetect
asner
et
al
pattern
heterogen
outpati
observ
howev
test
fewer
virus
use
singleplex
assay
clinic
consequ
codetect
respiratori
virus
well
understood
studi
show
codetect
rel
common
ili
sari
limit
howev
consid
name
case
select
includ
adult
children
lack
control
comorbid
overal
two
method
compar
studi
show
excel
satisfactori
agreement
detect
respiratori
virus
except
influenza
b
approach
offer
contrast
advantag
drawback
term
number
pathogen
detect
speed
analysi
per
specimen
cost
order
select
suitabl
diagnost
platform
laboratori
consid
valu
assay
context
routin
surveil
outbreak
situat
better
understand
resourcebenefit
